Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Wierdsma Thomas M
   2. Issuer Name and Ticker or Trading Symbol
GEO GROUP INC [GEO] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP - Project Development
(Last)
(First)
(Middle)
ONE PARK PLACE, SUITE 700, 621 NW 53RD STREET		 3. Date of Earliest Transaction (Month/Day/Year)
12/31/2012
(Street)

BOCA RATON, FL 33487		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2012   S   4,339 (1) D $ 29.12 10,185 (2) D  
Restricted Stock               30,528 (3) D  
Common Stock               120 (4) I By self as custodian for B. Wierdsma
Common Stock               120 (4) I By self as custodian for Oliver Thomas Adams
Common Stock               120 (4) I By self as custodian for Lauren Diane Wierdsma
Common Stock               120 (4) I By Self as custodian for Robert Oliver Weirdsman

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 21.07             10/28/2009 10/28/2019 Common Stock 7,500   7,500 D  
Stock Option $ 24.61             03/01/2011 03/01/2021 Common Stock 7,500   7,500 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Wierdsma Thomas M
ONE PARK PLACE, SUITE 700
621 NW 53RD STREET
BOCA RATON, FL 33487		       SVP - Project Development  

Signatures

 /s/ Thomas M. Wierdsma By: John J. Bulfin as Attorney-in-Fact   01/03/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These shares were sold by the reporting person to The GEO Group, Inc. ("GEO") under GEO's stock repurchase program at the closing price of GEO's common stock on December 12, 2012, the record date for GEO's special dividend described in footnote (2) below. The sale was approved by GEO's Audit and Finance Committee. The reporting person used all or a portion of the proceeds from the sale of the securities to finance the reporting person's equity participation in GEO Care Holdings LLC, an entity formed by members of GEO and GEO Care, Inc.'s management teams (the "MBO Group"), in connection with the previously announced acquisition by the MBO Group of certain health care facility management contracts (the "GEO Care Business") from GEO. The sale of the GEO Care Business closed on December 31, 2012.
(2) The amount of shares reflects the prior vesting of 3,000 shares of restricted stock. Additionally, on December 6, 2012, the Board of Directors of GEO declared a special dividend of $5.68 per share of common stock, representing approximately $350 million of accumulated earnings and profits, which was paid on December 31, 2012 to shareholders of record as of December 12, 2012. As a result, the reporting person received 1,701 shares of GEO common stock pursuant to the special dividend.
(3) The amount of shares has been adjusted to reflect the prior vesting of 3,000 shares of restricted stock. Additionally, as a result of the special dividend described in footnote (2) above, the reporting person received 4,028 shares of GEO common stock pursuant to the special dividend.
(4) As a result of the special dividend described in footnote (2) above, the reporting person received 20 shares of GEO common stock pursuant to the special dividend.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.